Acumen Pharmaceuticals, Inc. Liquidation Value
ABOS
Other
Cash & Equivalents
$53.99M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $53.99M
Total Obligations: -$52.55M
$1.44M
Per share: $0.02
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $53.99M
AR: $625,000
Total Obligations: -$52.55M
$2.06M
Per share: $0.03
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $53.99M
AR: $625,000
Inventory: $0
Total Obligations: -$52.55M
$2.06M
Per share: $0.03
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $1.44M | $0.02 |
| Liquid Liquidation Value | $2.06M | $0.03 |
| Operating Liquidation Value | $2.06M | $0.03 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $53.99M |
| Accounts Receivable | $625,000 |
| Inventory | N/A |
| Current Liabilities | $30.01M |
| Long-term Debt | $22.40M |
| Op. Lease Liability | $150,000 |
| Finance Lease | N/A |
| Shares Outstanding | 60.6M |
Explore all 146 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $53.99M | $625,000 | N/A | $554,000 | $30.01M | $22.40M | $150,000 | N/A |
| 2025-09-30 | $46.83M | $379,000 | N/A | $682,000 | $21.96M | $27.05M | $185,000 | N/A |
| 2025-06-30 | $36.81M | $315,000 | N/A | $2.10M | $24.86M | $29.88M | $219,000 | N/A |
| 2025-03-31 | $30.16M | $376,000 | N/A | $1.06M | $19.32M | $29.53M | $252,000 | N/A |
▼ Community Notes